Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/Biomarker Study of Bevacizumab in Combination With CNTO 95 in Patients With Refractory Solid Tumors

NCT00888043 is registered in ClinicalTrials.gov with Herbert Hurwitz, MD as lead sponsor.

NCT NCT00888043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00888043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/Biomarker Study of Bevacizumab in Combination With CNTO 95 in Patients With Refractory Solid Tumors
Lead sponsor
Herbert Hurwitz, MD
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2009
Completion date
January 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors